Company lists · Data refreshed September 2026
Top 25 Oncology drug developers worldwide
RevenueBase identified 2,399 oncology drug developers worldwide as of September 2026 and tracks 90,983 professional contacts across them, including 32,548 with verified work emails. The United States is the largest market and San Diego the largest hub.
This list covers oncology drug developers worldwide, matched on what each company actually does as described in its own words. Ranked by team size, largest first. Every row shows the company's own description, its RevenueBase Smart Search rating, and when it was last checked. Data refreshed September 20, 2026. Country and city lists for oncology drug developers follow the table.
Published by RevenueBase, a B2B data infrastructure company. This list was built with RevenueBase Smart Search, the natural-language company search RevenueBase customers use to build their own targeted lists and unlock verified emails and direct dials at the companies on them. How these lists are built and judged.
The 25 largest oncology drug developers worldwide
Ranked by team size| # | Company | Contacts | |||
|---|---|---|---|---|---|
| 1 | 3,766 contacts → | ||||
Indirect evidence “At Kite, a Gilead Company, our singular focus is achieving cures with cell therapy.” Source: RevenueBase Database · checked Sep 20, 2026Thanks. The Data Team will review it. | |||||
| 2 | 2,135 contacts → | ||||
Indirect evidence “Effective March 17, 2025, The U.S.” Source: RevenueBase Database · checked Sep 20, 2026Thanks. The Data Team will review it. | |||||
| 3 | 1,580 contacts → | ||||
Indirect evidence “At Novartis, our mission is to discover new ways to improve and extend people's lives.” Source: RevenueBase Database · checked Sep 20, 2026Thanks. The Data Team will review it. | |||||
| 4 | 1,447 contacts → | ||||
Partial evidence “Novocure is a global oncology company working to extend survival in some of the most aggressive forms of cancer through the development and commercialization of its innovative…” Source: RevenueBase Database · checked Sep 20, 2026Thanks. The Data Team will review it. | |||||
| 5 | 1,443 contacts → | ||||
Indirect evidence “Icon Group is a leading integrated healthcare provider with global reach across Australia, New Zealand, ASEAN, the United Kingdom and Germany.” Source: RevenueBase Database · checked Sep 20, 2026Thanks. The Data Team will review it. | |||||
| 6 | 1,426 contacts → | ||||
Indirect evidence “Every Exelixis employee is united in an ambitious cause: to transform science into new treatments that give cancer patients and their families hope for the future.” Source: RevenueBase Database · checked Sep 20, 2026Thanks. The Data Team will review it. | |||||
| 7 | 1,364 contacts → | ||||
Partial evidence “The IEO European Institute of Oncology is a Research Hospital (IRCCS) dedicated to the treatment of cancer.” Source: RevenueBase Database · checked Sep 20, 2026Thanks. The Data Team will review it. | |||||
| 8 | 1,126 contacts → | ||||
Indirect evidence “Daiichi Sankyo is a global healthcare company committed to becoming a trusted healthcare innovator, transforming the lives of people through its strength in science and technology.” Source: RevenueBase Database · checked Sep 20, 2026Thanks. The Data Team will review it. | |||||
| 9 | 879 contacts → | ||||
Indirect evidence “We are Revolutionaries – passionate in our singular pursuit of discovering, developing and delivering innovative, targeted medicines for patients living with cancer.” Source: RevenueBase Database · checked Sep 20, 2026Thanks. The Data Team will review it. | |||||
| 10 | 868 contacts → | ||||
Partial evidence “Sarah Cannon Research Institute (SCRI) is one of the world’s leading oncology research organizations, conducting community-based clinical trials.” Source: RevenueBase Database · checked Sep 20, 2026Thanks. The Data Team will review it. | |||||
| 11 | 857 contacts → | ||||
Indirect evidence “Seagen is now part of Pfizer!” Source: RevenueBase Database · checked Sep 20, 2026Thanks. The Data Team will review it. | |||||
| 12 | 816 contacts → | ||||
Indirect evidence “Following the merger of long-time partners, Fred Hutchinson Cancer Research Center and Seattle Cancer Care Alliance to form Fred Hutchinson Cancer Center, this page will no longer…” Source: RevenueBase Database · checked Sep 20, 2026Thanks. The Data Team will review it. | |||||
| 13 | 751 contacts → | ||||
Partial evidence “Founded in 1964, the American Society of Clinical Oncology (ASCO) is committed to making a world of difference in cancer care.” Source: RevenueBase Database · checked Sep 20, 2026Thanks. The Data Team will review it. | |||||
| 14 | 709 contacts → | ||||
Indirect evidence “VERSION FRANCAISE Centre multidisciplinaire intégré, unique en Belgique et reconnu internationalement, l’Institut Jules Bordet est un hôpital entièrement consacré aux patients…” Source: RevenueBase Database · checked Sep 20, 2026Thanks. The Data Team will review it. | |||||
| 15 | 683 contacts → | ||||
Indirect evidence “UT MD ANDERSON CANCER CENTER is a hospital & health care company based out of 1515 HOLCOMBE BLVD, Houston, Texas, United States.” Source: RevenueBase Database · checked Sep 20, 2026Thanks. The Data Team will review it. | |||||
| 16 | 677 contacts → | ||||
Indirect evidence “The Menarini Group ("Menarini"), a leading Italian pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc.("Stemline"), a wholly-owned subsidiary of the Menarini…” Source: RevenueBase Database · checked Sep 20, 2026Thanks. The Data Team will review it. | |||||
| 17 | 666 contacts → | ||||
Partial evidence “Under the leadership of Josep Tabernero, the Vall d’Hebron Institute of Oncology (VHIO) has established itself as a cancer research center of proven excellence internationally.” Source: RevenueBase Database · checked Sep 20, 2026Thanks. The Data Team will review it. | |||||
| 18 | 637 contacts → | ||||
Indirect evidence “Dendreon is a commercial-stage biopharmaceutical company and pioneer in the development of immunotherapy.” Source: RevenueBase Database · checked Sep 20, 2026Thanks. The Data Team will review it. | |||||
| 19 | 632 contacts → | ||||
Indirect evidence “Arcus Biosciences is a rapidly growing, clinical-stage, global biopharmaceutical company developing differentiated molecules and combination medicines that may have the potential…” Source: RevenueBase Database · checked Sep 20, 2026Thanks. The Data Team will review it. | |||||
| 20 | 630 contacts → | ||||
Partial evidence “Onco360 is recognized as one of the nation's leading independent specialty pharmacies dedicated exclusively to oncology and rare disease patients.” Source: RevenueBase Database · checked Sep 20, 2026Thanks. The Data Team will review it. | |||||
| 21 | 561 contacts → | ||||
Indirect evidence “The Netherlands Cancer Institute (NKI) is where cutting-edge cancer research and patient care come together.” Source: RevenueBase Database · checked Sep 20, 2026Thanks. The Data Team will review it. | |||||
| 22 | 546 contacts → | ||||
Indirect evidence “PASSION FOR PRECISION.” Source: RevenueBase Database · checked Sep 20, 2026Thanks. The Data Team will review it. | |||||
| 23 | 509 contacts → | ||||
Indirect evidence “The Spanish National Cancer Research Centre is a public institution of excellence committed to research, diagnosis and treatment for cancer.” Source: RevenueBase Database · checked Sep 20, 2026Thanks. The Data Team will review it. | |||||
| 24 | 501 contacts → | ||||
Indirect evidence “The IUCT-Oncopole, a center for care, research, and training in cancerology, mobilizes on a single site in Toulouse the expertise of professionals.” Source: RevenueBase Database · checked Sep 20, 2026Thanks. The Data Team will review it. | |||||
| 25 | 482 contacts → | ||||
Indirect evidence “Deciphera, a member of Ono Pharmaceutical Co, Ltd, is a commercial-stage biopharmaceutical company focused on discovering, developing and delivering novel, innovative medicines to…” Source: RevenueBase Database · checked Sep 20, 2026Thanks. The Data Team will review it. | |||||
RevenueBase Smart Search
RevenueBase Smart Search assesses information from a company’s LinkedIn profile, information supplied directly by the company, its website, and other publicly available sources. It uses that information to rate how closely the company relates to this list’s category: oncology drug developers. Every row carries its rating and the description the rating was read from, so each one can be checked rather than taken on trust.
- Strong evidence
- The company's own public description of its business names oncology drug developers.
- Partial evidence
- Its own public description names part of oncology drug developers, so it works in or next to the category without describing itself that way.
- Indirect evidence
- The description shown does not name oncology drug developers. The match rests on the rest of the company's public profile rather than the one sentence quoted here, so this is the rating to check first.
RevenueBase Smart Search is how these lists are built: RevenueBase's data engine and AI assemble the companies that match a category defined in a user's own words, so a list can be about what companies actually do rather than about whichever industry code they were filed under.
Showing 25 of 2,399 oncology drug developers worldwide
See the full list, filter by size, metro and specialty, and get verified emails and direct dials for all 32,548 reachable decision-makers.
Free signup · no credit card
Oncology drug developers worldwide at a glance
As of Sep 20, 2026Companies by employee count
Email recency is reported on each country list linked below.
How this list was built
Company categories are rarely black and white. RevenueBase reads each company's own description of its business to decide whether it belongs among oncology drug developers, so some rows will be adjacent to the category rather than pure plays. The description and RevenueBase Smart Search rating on every row are there so you can check each match yourself.
- Source
- The RevenueBase company graph: 60 million companies and 398.9 million professional contacts resolved from primary sources, queried with RevenueBase Smart Search, the natural-language company search available to every RevenueBase user.
- Coverage
- Every country. Country and city lists for oncology drug developers are linked below.
- What qualifies
- Companies worldwide whose own description of what they do matches “oncology drug developers”. Matching reads each company's description, not its industry code or its name.
- RevenueBase Smart Search
- RevenueBase Smart Search is how this list is assembled and how each row is rated. RevenueBase's data engine and AI assess a company's LinkedIn profile, information supplied directly by the company, its website and other publicly available information, then relate it to a category defined in a user's own words. Each row is rated strong evidence (its own description names oncology drug developers), partial evidence (it names part of the category) or indirect evidence (the description shown names none of it and the match rests on the rest of the company's profile). The description supporting each rating is quoted on the row.
- What we exclude
- Companies whose own description does not clearly place them among oncology drug developers, and records with no verified work email.
- Match quality
- In blind human judging of this matching method, 86% of matched companies were on target. Expect roughly 1 in 7 rows to be adjacent to the category rather than a pure play. Every row shows the company's own description and its RevenueBase Smart Search rating so you can judge each match yourself. Read the full methodology: how the lists are built, how the judging worked, and what the figure means.
- Ranking
- Team size, largest first: companies are ordered by the number of professionals RevenueBase tracks at each one. Employee ranges shown are reported bands, for context.
- Verification
- Every listed company carries at least one verified work email, 32,548 across the full list. Contacts re-verify on a rolling cadence, and each contact's own verification date is shown inside RevenueBase.
- Refresh
- This page's figures were pulled from the company graph on September 20, 2026. Lists refresh periodically as the graph is re-checked.
- Corrections
- Wrong category, wrong headquarters, or a company that has closed? Use “Report an issue” on any row. Reports go to the RevenueBase Data Team and feed back into the company graph.
Oncology drug developers by location
21 lists · largest firstEvery Oncology drug developers list RevenueBase publishes, by country and city. Counts are matching companies in each list as of its own refresh date.
Countries
- Oncology drug developers based in the United States929
- Oncology drug developers based in the United Kingdom126
- Oncology drug developers based in France100
- Oncology drug developers based in China92
- Oncology drug developers based in Canada70
- Oncology drug developers based in Germany69
- Oncology drug developers based in India68
- Oncology drug developers based in Switzerland51
- Oncology drug developers based in Australia46
- Oncology drug developers based in Spain43
- Oncology drug developers based in Italy39
- Oncology drug developers based in South Korea39
- Oncology drug developers based in Brazil35
- Oncology drug developers based in the Netherlands33
- Oncology drug developers based in Sweden32
- Oncology drug developers based in Taiwan25
Cities
Frequently asked
What is RevenueBase Smart Search?
RevenueBase Smart Search is how RevenueBase decides which companies belong on this list and how strongly each one fits. Its data engine and AI assess a company's LinkedIn profile, information supplied directly by the company, its website and other publicly available information, then relate it to the category the list is about. Each row is rated strong evidence when the company's own description names oncology drug developers, partial evidence when it names part of the category, and indirect evidence when the description shown names none of it and the match rests on the rest of the company's profile.
How many oncology drug developers are there worldwide?
RevenueBase identified 2,399 oncology drug developers worldwide as of September 2026, matched on each company's own description of what it does rather than its industry code.
What is the largest company on this list?
Kite Pharma, headquartered in Santa Monica, tops this list with the largest team on record.
Which country has the most oncology drug developers?
The United States leads with 929 companies, followed by the United Kingdom (126) and France (100). Every oncology drug developers list by country and city is linked on this page.
Which city has the most oncology drug developers?
San Diego leads with 70 headquartered companies, followed by Cambridge (68) and New York (48).
How do I get contact information for these companies?
A free RevenueBase account lets you run this exact search and work the top results, verified emails and direct dials included. Upgrading unlocks all 32,548 verified decision-maker contacts tracked across these 2,399 companies.
How current is this list?
The list refreshes periodically as the company graph is re-checked. This page's figures were pulled on September 20, 2026.
Ready to reach these companies? Verified emails and direct dials for all 2,399 oncology drug developers worldwide. Start with a free account, no credit card.
Download this list →Related lists
Browse the directory
About this data
RevenueBase is a B2B data infrastructure company. Its company graph covers 60 million companies and 398.9 million professional contacts, with emails verified on a rolling cadence rather than scraped once and left to decay. These company lists are generated directly from that graph with RevenueBase Smart Search, the same natural-language company search every RevenueBase user has: describe a market in plain words, get the companies that match, and add verified emails and direct dials for the people at them. It is the same data that powers RevenueBase's B2B data products, and a free account includes 500 credits to start. How these lists are built and judged.